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Abstract
Background: The family of lysosome-associated membrane proteins (LAMP) comprises the multifunctional,
ubiquitous LAMP-1 and LAMP-2, and the cell type-specific proteins DC-LAMP (LAMP-3), BAD-LAMP (UNC-46,
C20orf103) and macrosialin (CD68). LAMPs have been implicated in a multitude of cellular processes, including
phagocytosis, autophagy, lipid transport and aging. LAMP-2 isoform A acts as a receptor in chaperone-mediated
autophagy. LAMP-2 deficiency causes the fatal Danon disease. The abundant proteins LAMP-1 and LAMP-2 are
major constituents of the glycoconjugate coat present on the inside of the lysosomal membrane, the ‘lysosomal
glycocalyx’. The LAMP family is characterized by a conserved domain of 150 to 200 amino acids with two disulfide
bonds.
Results: The crystal structure of the conserved domain of human DC-LAMP was solved. It is the first high-
resolution structure of a heavily glycosylated lysosomal membrane protein. The structure represents a novel
b-prism fold formed by two b-sheets bent by b-bulges and connected by a disulfide bond. Flexible loops and a
hydrophobic pocket represent possible sites of molecular interaction. Computational models of the glycosylated
luminal regions of LAMP-1 and LAMP-2 indicate that the proteins adopt a compact conformation in close
proximity to the lysosomal membrane. The models correspond to the thickness of the lysosomal glycoprotein coat
of only 5 to 12 nm, according to electron microscopy.
Conclusion: The conserved luminal domain of lysosome-associated membrane proteins forms a previously
unknown b-prism fold. Insights into the structure of the lysosomal glycoprotein coat were obtained by
computational models of the LAMP-1 and LAMP-2 luminal regions.
Background
Lysosomes of mammalian cells typically appear as small,
spherical bodies with amorphous, electron-dense cores
and a single limiting membrane. The interior of lysosomes
is acidic at pH 4.8. Lysosomes contain an array of hydro-
lases with acidic pH optimum that can degrade all cellular
macromolecules. Three mechanisms provide substrates
for lysosomal degradation: endocytosis, autophagy and
phagocytosis.
Newly synthesized lysosomal proteins exit the trans-
Golgi network in vesicles which fuse with endosomes [1].
Soluble lysosomal enzymes are tagged with mannose-6-
phosphate and are sorted in the Golgi compartment by
mannose-6-phosphate receptors. Lysosomal membrane
proteins have sorting signals in their cytosolic domains.
Early endosomes acquire lysosomal proteins and an acidic
pH during their maturation to late endosomes [2].
Lysosomes can be distinguished from endosomes by the
absence of mannose-6-phosphate receptors, a lower inter-
nal pH and a distinct morphology [3]. Lysosomes appear
electron dense by comparison with endosomes and can be
separated by density gradient centrifugation. Lysosomes
may be regarded as storage organelles for degradative
enzymes, with the degradation of substrates occurring
mainly in hybrid organelles of late endosomes and (auto)
phagosomes [4]. Endosomes deliver endocytosed mole-
cules from the extracellular space for degradation, and
also proteins provided by the ESCRT pathway. ESCRT
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complexes package ubiquitinated proteins into vesicles
formed by inward budding of the endosomal limiting
membrane. Fusion of a late endosome with lysosomes cre-
ates a hybrid organelle of intermediate density [5]. The
hybrid organelle hydrolyses its cargo - macromolecules
and intraluminal vesicles - and transports the small mole-
cular products into the cytosol. The remaining lysosomal
components are condensed and form new dense-core
lysosomes [6].
The lysosome’s degradative machinery is potentially
harmful to its limiting membrane, since it is capable of
degrading intact lipid membranes. The inside of the
lysosomal membrane is protected from degradation, pre-
sumably by a high abundance of heavily glycosylated
membrane proteins. The membrane is quickly degraded
when its glycoconjugate-free outside is exposed to the
lysosomal interior [7].
Lysosomes are characterized by a high abundance of
heavily glycosylated membrane proteins. These proteins
form a dense coat on the inside of the lysosomal mem-
brane. The glycoprotein coat can be visualized by electron
microscopy as a thin, electron translucent halo separating
the membrane from the condensed core [8,9]. It can be
stained by glycoprotein-specific reagents and its thickness
ranges from 5 to 12 nm with an average of 8 nm [8,9]. In
comparison, the glycocalyx on the cell surface is much
thicker, up to several micrometers [10]. Intracellular glyco-
protein membrane coats were observed in lysosomes,
endosomes, autophagosomes and secretory granules [9].
They are believed to protect vesicle membranes by limit-
ing the access of degradative factors to the lipid bilayer.
The major lysosomal membrane proteins, the homolo-
gous LAMP-1 (lgp120, CD107a) and LAMP-2 (lgp110,
CD107b), are the standard markers for the lysosomal
compartment [11]. They are among the most extensively
glycosylated proteins with glycan chains that outweigh
the protein core and that include high-molecular-weight
poly-N-acetyllactosaminoglycans [12]. LAMP-1 and 2 are
type-I membrane proteins of similar length and identical
domain structure. The transmembrane region is followed
by a short, C-terminal cytosolic tail that comprises motifs
for lysosomal targeting [1]. The luminal region comprises
two similar N-glycosylated domains of about 160 resi-
dues, each with two conserved disulfide bonds (Figure 1).
The two domains are separated by a proline-rich, O-gly-
cosylated ‘hinge’ region of about 30 amino acid residues
[13].
LAMP-1 and LAMP-2 are abundant proteins, repre-
senting 0.1 to 0.2% of total cell protein [14]. They are
enriched in lysosomes, late endosomes and mature (auto)
phagosomes. Both proteins are ubiquitous in human tis-
sues and cell types [15]. Their expression is particularly
pronounced in metabolically active cells. The LAMP-2
gene has three splice forms, LAMP-2A, -2B, -2C, which
differ in the transmembrane and cytosolic regions [15].
The LAMP-1 gene encodes for a single transcript.
Considerable knowledge on LAMP function was
derived from LAMP-1 and LAMP-2 gene knockout mice
[16,17] and LAMP-1/2-negative cell lines [18]. Impaired
fusion of phagosomes and autophagosomes with lyso-
somes was observed. LAMP-1 and 2 can complement
each other to a large extent. Double LAMP-1/2 knock-
out leads to embryonic lethality. In contrast, LAMP-1
knockout mice are healthy [16]. They display upregu-
lated levels of LAMP-2. Knockout of the LAMP-2 gene
leads to elevated postnatal mortality [17]. Surviving mice
have a phenotype that corresponds to Danon disease, a
rare genetic condition caused by LAMP-2 deficiency
[19]. Autophagosomes accumulate in several tissues of
LAMP-2 negative mice. Danon disease entails muscle
weakness, heart disease and mental retardation. It is
associated with disturbed autophagosome maturation
and extensive accumulation of autophagosomes in mus-
cle cells.
LAMP proteins are important regulators of lysosome
fusion with autophagosomes and phagosomes [20].
Macrophages lacking either LAMP-1 or LAMP-2 are
capable of normal phagocytosis. However, knockout of
both genes interferes with fusion of phagosomes with
lysosomes [21,22]. Phagosomes lacking both LAMP-1
and 2 did not move from the periphery of the cell
towards the perinuclear lysosomes [21]. In contrast to
macrophages, LAMP-1 cannot compensate for lack of
LAMP-2 in neutrophil phagocytes. LAMP-2 knockout
mice suffer from a high prevalence of periodontitis
because their neutrophils cannot keep the responsible
bacteria in check [23].
LAMP-2 has been implicated in cholesterol transport
from the lysosome [18,24]. It was shown that the mem-
brane-proximal luminal domain of LAMP-2 is specifically
required to rescue the cholesterol transport deficiency of
LAMP-1/2 double knockout cells [24].
LAMP-1 and 2 are major components of the glycocon-
jugate coat on the inside of the lysosomal membrane. It
was estimated that the concentration of LAMPs is suffi-
ciently high for the formation of a nearly continuous
layer on the inner surface of the lysosomal membrane
[25]. It was, therefore, expected that their removal would
destabilize lysosomes. However, depletion of LAMP-1
and 2 had no detectable effect on lysosome integrity.
Removal of N-linked glycans with endoglycosidase H
caused rapid degradation of LAMP-1 and LAMP-2, but
did not destabilize lysosomes [26]. Lysosomes of LAMP-
1/2 knockout cells have abnormalities, but their limiting
membranes are apparently intact [18]. Other glycopro-
teins and glycolipids might have provided sufficient
membrane protection in these studies. Lysosomal hybrid
organelles with larger limiting membrane surface and
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Figure 1 The LAMP protein family. (A) Domain architectures of the five human LAMP family proteins (UniProt P11279, P13473, Q9UQV4,
Q9UJQ1, P34810). O- and N-linked glycosylation sites are indicated in blue and red, respectively. SP, signal peptide; TM, transmembrane helix. (B,
C) Sequence alignments of the seven human LAMP domains and adjacent transmembrane domains (B) and of the ‘hinge’ region (linker)
connecting the membrane-distal (’dist’) and membrane-proximal (’prox’) domains of LAMP-1 and LAMP-2 (C). Glycosylated residues are displayed
with yellow background. Residues involved in b-bulges are indicated by arcs in magenta. Hydrophobic residues are colored red and hydrophilic
ones are colored blue (in B). S-S: disulfide bond.
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lower membrane glycoprotein density might be more
dependent on LAMPs for protecting their membranes.
Intracellular glycoconjugate coats are found on the
membranes of secretory granules [9]. During degranula-
tion of Natural Killer (NK) or cytotoxic T-cells, cytotoxic
effectors become activated, which can potentially harm
the effector cells’ cell membrane. LAMP-1 is a surface
marker of NK cells that have degranulated. It can protect
NK cells against their own cytotoxic effectors following
degranulation (André Cohnen, University of Heidelberg,
Carsten Watzl, Leibniz Research Centre for Working
Environment, unpublished data).
Chaperone-mediated autophagy (CMA) is a lysosomal
pathway for selective removal of damaged cytosolic pro-
teins (reviewed in [27]). CMA effects direct transmem-
brane import of cytosolic proteins into the endolysosomal
system. The LAMP-2 isoform LAMP-2A functions as a
receptor for cytosolic proteins and also as essential com-
ponent of the CMA translocation complex [28]. Cytosolic
substrate proteins bind to monomers of LAMP-2A, which
then multimerizes to form the complex required for sub-
strate transmembrane import. Membrane-associated
molecules of hsc70 actively disassemble LAMP-2A into
monomers to initiate a new cycle of binding and transloca-
tion [28]. Expression of LAMP-2A normally declines in
the liver of mice as they age. Genetic engineering for over-
expression of LAMP-2A in the liver not only restored
CMA, but also (macro)autophagy and proteasomal path-
ways to the levels observed in young animals. As a result,
the age-related decline of liver function was significantly
reduced [29].
The five human members of the LAMP protein family
are characterized by a conserved ‘LAMP domain’ directly
adjacent to the single transmembrane helix (Figure 1).
LAMP-1 and 2 are ubiquitous proteins, whereas DC-
LAMP (LAMP-3) [30], BAD-LAMP (UNC-46, C20orf103)
[31] and macrosialin (CD68) [32] are only expressed in
specific cell types.
Dendritic cells (DCs) are professional antigen-presenting
cells with the task of activating immune responses. DC-
LAMP levels increase progressively during the differentia-
tion of human DCs from hematopoietic bone marrow pro-
genitor cells. DCs search for pathogens in tissues in
contact with the external environment. They phagocytose
pathogens, become activated and migrate to lymph nodes
where they present pathogen-specific antigens on their cell
surface using MHC class II molecules. DC-LAMP levels
rises steeply upon activation of human DCs [30]. The pro-
tein co-localizes with MHC class II molecules in an intra-
cellular compartment. DC-LAMP is a highly specific
marker for mature DCs in humans and other mammals
including cattle and pigs, but it is not expressed in DCs of
mice [33].
Mammals, including mice, have a second cell type
with high DC-LAMP expression: type II pneumocytes
[34]. These cells secrete the lung’s surfactant and, like
DCs, can present antigens of pathogens on MHC class
II molecules [35,36]. DC-LAMP co-localizes with MHC
class II molecules on the limiting membrane of surfac-
tant protein-containing organelles [34]. In chicken, DC-
LAMP expression is upregulated upon DC activation
[37]. In contrast to mammals, DC-LAMP was found in
nearly all chicken tissues tested.
The structural basis of the various and seemingly
unrelated functions of the lysosome associated mem-
brane proteins is currently unclear. No information
about the three-dimensional structures of any of the
highly glycosylated proteins that form the inner lysoso-
mal membrane coat were available before this study and
the structural basis for the electron microscopical
appearance of the coat has remained unclear. Previously,
we established a novel expression system for glycosy-
lated proteins. With this system, stable cell lines for a
number of LAMP domains were established and crystals
of the membrane-proximal domain of human DC-
LAMP (LAMP-3) were obtained [38,39]. Here we report
the structure solved with these crystals. Unexpected
structural features and possible sites of molecular inter-
actions were uncovered. In silico models of LAMP-1
and LAMP-2 were generated that allowed us to draw
conclusions on the structure of the lysosomal membrane
coat.
Results
The DC-LAMP domain has a novel b-prism fold
The crystal structure of the membrane-proximal domain
of human DC-LAMP (Figure 1) was solved by multi-
wavelength anomalous dispersion (MAD) phasing and
refined at a resolution of 2.8 Å (Table 1). Two protein
molecules denoted chain A and B are present in the
asymmetric unit, which are related to each other by a
two-fold non-crystallographic symmetry. Analysis with
the protein interfaces, surfaces and assemblies service
PISA [40] predicted that the domain is a monomer in
solution, in correspondence with gel filtration results.
Chains A and B have almost identical conformations
except for one loop, which adopts two distinct confor-
mations (discussed below). This is reflected by an r.m.s.
distance for the aligned chains’ Ca atoms of 0.39 Å if
this loop is excluded and of 2.1 Å if the loop is
included. If not otherwise noted, the following sections
refer to chain A, which is based on a better defined
electron density map.
The DC-LAMP domain consists of two b-sheets that
form a “pseudo b-prism” (Figure 2). According to the
SCOP database [41], the pseudo b-prism fold consists of
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a b-sandwich with one regular b-sheet and the other
b-sheet bent in the middle with a set of aligned b-
bulges. The triangular base of the domain’s prism shape
is 60 Å wide and 35 Å high and the prism’s height is
35 Å. The domain’s N- and C-termini are located on the
‘front’ b-sheet, which consists of 6 b-strands (Figure 3).
b-strands S1 and S3 are short and arranged in tandem,
antiparallel to strand S2. Two more antiparallel b-strands,
S10 and S9, are followed by the short C-terminal b-strand
S11, which is arranged in parallel to S9.




Dataset type Peak Inflection point High-energy remote
Wavelength (Å) 1.10371 1.10420 1.10009
Data range (°) 180
Oscillation range (°) 0.5
Space group P31
Unit cell parameters (Å) a = b = 53.0, c = 143.5
Resolution (Å) 20 to 2.8 (2.95 to 2.8)
Unique reflections 19,800 (3,352) 19,790 (3,392) 19,765 (3,365)
Redundancy 2.84 (2.84) 2.83 (2.82) 2.84 (2.84)
Completeness (%) 90.0 (94.5) 89.9 (96.9) 89.7 (95.9)
Mean I/sI 16.5 (3.45) 15.52 (2.92) 18.19 (3.84)
Rmerge
a 0.05 (0.30) 0.06 (0.40) 0.05 (0.28)
Mosaicity (°) 0.271














Atomic displacement factor B (Å2) 61.3
Real space correlation coefficientd 0.882
r.m.s.d. from ideal
Bond lengths (Å) 0.0056
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Figure 2 The structure of the DC-LAMP domain. (A) Different views of the domain’s shape. The two b-sheets are drawn in red and blue. (B)
Stereo views of the domain’s b-prism shape. Schematic prism shapes are drawn on the right for orientation. The N-acetyl-glucosamine residue is
depicted as a stick drawing in cyan.
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The front b-sheet is bent in the middle by two con-
nected b-bulges [42], which are formed by the b-strand
pairs S2/S10 and S10/S9 (Figure 4). This bending forms
the domain’s triangular prism shape and it opens a
hydrophobic pocket between the sheets, constituting a
possible binding site for small molecules (Figure 5A).
The ‘back’ b-sheet consists of five antiparallel b-strands
(Figure 3). Strand S4 comprises only four residues, 268 to
271, but the polypeptide chain continues in a b-strand-
like conformation up to residue 275. It is distorted by the
disulfide bond formed by cysteines 274 and 311. The
back b-sheet is flat, except for the lower left corner,
which is bent as if to close the opening of the domain
created by the bending of the front b-sheet (Figure 2B).
The bending of the back b-sheet is caused by three
b-bulges between strands S6, S7 and S8 (Figure 4).
The domain’s b-strands are connected by b-turns and
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Figure 3 The b-strand arrangement of the DC-LAMP domain. The ‘front’ and ‘back’ b-sheets are drawn in red and blue, respectively. The
cysteines that form the first disulfide bond (S-S) are labelled. b-strands and loops are identified as S1 to S11 and L1 to L3, respectively. The
topology of the b-sheets is drawn schematically in the lower part with sheets opened out.
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Figure 4 Stereo views of the b-bulges. The b-bulges that bend the front and back b-sheets are shown. Main chain atoms of parts of b-strands
are shown as stick drawings. Bulged residues are numbered and their conformations are given in parentheses (a, a-helix; b, b-strand; I’, type I’ b-
turn; La, left-handed a-helix). Hydrogen bond pairs that flank b-bulges are shown in red and the corresponding residues are labelled. Other
inter-main chain hydrogen bonds are drawn in grey.
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back b-sheet (Figure 3). Two more loops of 6 and 10
residues connect strands S2 and S3 (Loop L1) and S10
and S11 (Loop L3), respectively. The conformation of
loop L1 and the adjacent b-hairpin formed by strands
S7 and S8 differs between chains A and B, due to crystal
contacts, indicating that these regions are flexible in
solution (Figure 5B). Several hydrogen bonds link loop
L1 and the hairpin in chain A, but not in chain B.
According to the SCOP database [41], only two pro-
teins are known to contain pseudo b-prism domains, a
carbohydrate receptor binding protein of Lactococcus
lactis phage P2 (UniProt Q71AW2, PDB 1ZRU, 2-140)
[43] and a tail protein of Bordetella phage BPP-1 (Uni-
Prot Q775D6, PDB 1YU0, 5-170) [44]. The topology of
the b-sheets (that is, the order of the b-strands) of the
DC-LAMP domain differs from the other pseudo b-
prism structures. The DC-LAMP domain therefore
represents a novel fold (Alexey Murzin, personal
communication).
Two disulfide bonds and an N-acetylglucosamine resi-
due connected to Asn291 were visible in the DC-LAMP
domain’s electron density map (Figure 2B). The first
disulfide bond stabilizes the b-prism by linking its two
sheets. The second disulfide bond, linking the front b-
sheet and the domain’s C-terminus, strengthens the
connection of the C-terminal transmembrane helix to
the center of the front b-sheet. Interestingly, the N-acet-
ylglucosamine at Asn291 participated in formation of
the crystal lattice by forming a hydrogen bond to
Gly287 of a neighboring protein molecule.
The LAMP domain shares features with immunoglo-
bulin (Ig) domains (Figure 5C). Both domain types have
an all-b fold of comparable size stabilized by a con-
served disulfide bond between their two b-sheets. The
variable Ig domains of antibodies contain three flexible
loops forming the antigen-binding site, the complemen-
tarity determining regions (CDRs). Loop L1 and the
adjacent b-hairpin of the LAMP domain are also flexible
(Figure 5B) and might provide a site for specific molecu-
lar interactions.
Models of glycosylated LAMP domains
The N-terminal segment of the luminal region of DC-



















Figure 5 The hydrophobic pocket and the variable loop conformation. (A) The hydrophobic pocket in the DC-LAMP domain was filled with
water molecules, which are displayed as a red surface, using HOLLOW [70]. (B) Structural alignment of DC-LAMP chain A (grey) and B (blue).
Hydrogen bonds connect loop L1 to an adjacent hairpin in chain A, but not in chain B. (C) A VH immunoglobulin domain is shown for
comparison (PDB 1IGT). Complementarity determining regions (CDR) are drawn as red loops. The two b-sheets of the domain, displayed in
green and blue, are connected by a disulfide bond (S-S).
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(residues 28 to 221, Figure 1A), which implies an elon-
gated, stiffened conformation due to steric restraints
imposed by the glycan moieties [45]. A model of glyco-
sylated full length DC-LAMP was drawn to scale with
the domain’s C-terminus pointing down towards the
membrane (Figure 6). In this orientation, the protein’s
N-terminal segment is linked to the domain’s side at
about half height, suggesting an orientation of the N-
terminal segment along the membrane.
The highly abundant LAMP proteins 1 and 2 are the
main components of the thin coat present on the inside
of lysosomal membranes. The conformation of their
luminal domains in the coat is currently unclear. Struc-
tural models of the membrane-distal and membrane-
proximal domains of LAMP-1 and LAMP-2 were gener-
ated by comparative modelling with [46] using DC-
LAMP chain A as the template. Glycans of complex
type were attached to the models with [47] and GLY-
CAM [48]. The resulting glycosylated domain structures
had diameters of 6 to 9 nm. This corresponds to the
thickness of the glycoconjugate coat of the lysosomal
membrane, which was reported to range from 5 to
























Figure 6 Model of lysosomal membrane proteins and the glycoprotein coat. Structural models of glycosylated DC-LAMP and LAMP-1 were
drawn to scale. The models are based on the DC-LAMP crystal structure and a hypothetical in silico model of LAMP-1. The thickness of the
glycoprotein coat was reported to range from 5 to 12 nm with an average of 8 nm. The membrane-distal, N-terminal domain of LAMP-1 may
adopt other positions. Dotted lines indicate putative binding sites consisting of the flexible loop L1 and an adjacent b-hairpin (Figure 5B). A box
corresponding to 120 nm2 surface area was drawn around a top view of LAMP-1. Polypeptides are depicted in green and glycans in yellow.
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The two domains of LAMP-1 are connected by a lin-
ker of 23 residues, which comprises 11 prolines and 6
O-glycosylation sites in LAMP-1 (Figure 1C). This
implies an elongated conformation lacking secondary
structure and limited flexibility of the peptide backbone.
The linker of LAMP-2 has similar length but more gly-
cosylation sites. Conformational properties of the
LAMP-1 linker were analysed by computational folding
simulation. The sequence 196PSPTTAPPAPPSPSPSP212
was subjected to a 12 ns simulation with AMBER force
fields. The initial structure had an elongated b-strand
conformation and carried sialylated O-glycans on the six
Ser/Thr residues. During the simulation, folding was not
observed (Figure 7). Residues departed from the initial b-
strand conformation only transiently, except for prolines
203 and 206, which adopted a-helical conformations per-
manently. High values for the radius of gyration indicated
elongated conformations throughout the simulation (Fig-
ure 7B). During the simulation, root-mean-square devia-
tions of the backbone atoms from the lowest energy
structure were in the order of 3 to 5 Å, indicated a high
degree of structural flexibility (Figure 7B).
According to the in silico models, the N-termini of the
membrane-proximal domains of LAMP-1 and LAMP-2
are localized on the side, as described above for the DC-






































Figure 7 Molecular modeling. (A) The structure of the lowest energy obtained by molecular dynamics simulation is shown as a stick model
and a van der Waals surface with pink carbon atoms. Glycans are shown with yellow carbon atoms. Prolines 203 and 206 have a-helical
conformations. (B) Radius of gyration values during the simulation and r.m.s. deviations of the backbone atoms from the structure of lowest
energy (marked in red). The peptide’s lowest-energy structure had a radius of gyration of 14.6 Å, compared to 17.9 Å for the initial structure.
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distal domains to localize close to the membrane. The
models of the LAMP-1 domains and linker were com-
bined into a model of the complete molecule (Figure 6). In
the model, the dimensions of the luminal domain of
LAMP-1 agree well with the reported thickness of the
lysosomal glycoprotein coat. The model represents a pos-
sible conformation in which the linker is oriented horizon-
tally and the N-terminal domain is located relatively close
to the membrane. Alternative conformations with the lin-
ker pointing upwards appear less favorable due to steric
hindrance and electrostatic repulsion of the sialic acid
groups on the N- and O-linked glycans.
Discussion
The crystal structure of the membrane-proximal domain
of DC-LAMP reveals a novel b-prism fold. It is the first
structure reported for the heavily glycosylated lysosomal
membrane proteins. The structure proves that the pro-
teinaceous core of these proteins can adopt a globular
compact fold that is not fundamentally different from
proteins with less glycosylation.
The structure explains the complete conservation of
the pair of disulfide bonds in the LAMP protein family.
The first disulfide bond stabilizes the b-prism, while the
second disulfide bond fixes the domain’s C-terminus to
the center of the kinked b-sheet. The center of the sheet
is thereby linked to the transmembrane helix. Loop L3,
the flexible loop L1 and the adjacent b-hairpin point
sideways. In this arrangement, the loops would be in a
suitable position for interacting with luminal domains of
neighboring membrane proteins.
The LAMP family is characterized by a conserved,
membrane-proximal domain. Sequence conservation is
not restricted to this domain, but includes the adjacent
transmembrane helices (Figure 1B). All human LAMPs
contain a conserved proline and two conserved glycine
residues in the transmembrane helix. Glycine residues
mediate interactions of transmembrane helices in mem-
brane proteins [49]. In the course of chaperone-mediated
autophagy (CMA), LAMP-2A oligomerizes into multi-
meric complexes. Mutation of the conserved glycines in
the LAMP-2A transmembrane region to alanines inhibits
oligomerization and significantly reduces CMA activity
[28]. The lysosomal polypeptide transporter TAPL
(ABCB9) has recently been identified as a specific binding
partner of LAMP-1 and LAMP-2 [50]. The interaction
appears to be mediated by transmembrane regions: the
binding site for the LAMPs is localized in the N-terminal
domain of TAPL, which comprises four transmembrane
helices but no globular domains. The LAMP-2B isoform
is recognized exclusively by TAPL, which differs from
LAMP-2A only in the transmembrane region and the
cytosolic tail. The structure solved in this study identified
a possible protein binding site (Figure 5B). It is possible
that LAMPs self-oligomerize or recognize other lysoso-
mal membrane proteins by simultaneous interactions
with their luminal and transmembrane regions. The
LAMP family member unc-46 (BAD-LAMP) and the
vesicular GABA transporter depend on each other for
their vesicular sorting [51]. This phenomenon might be
due to molecular interaction of the two proteins.
The dimensions of the in silico models are consistent
with literature data on the thickness of the glycoprotein
coat on the lysosomal membrane (Figure 6) and the
density of LAMP molecules on the lysosomal mem-
brane. In BHK cells, the surface area of lysosomal and
LAMP-1 positive prelysosomal membranes was deter-
mined as 370 μm2/cell [52]. The average volume of the
cells was 1,400 μm3 [53]. LAMP-1 represents approxi-
mately 0.1% of the total cellular protein content of
200 to 250 mg/ml [25]. This amounts to a density of
LAMP-1 in lysosomal membranes of approximately
2,600 molecules/μm2. The footprint of the LAMP-1
model in Figure 6 is about 120 nm2, which would impli-
cate that about one third of lysosomal membranes is
covered by LAMP-1. The model thus supports the con-
cept of a continuous glycoprotein layer formed by
LAMP-1, the similar LAMP-2 and other lysosomal
proteins.
The luminal regions of lysosomal membrane proteins
are typically small and do not contain more than a single
folded domain. A comprehensive list of 45 lysosomal
membrane proteins [54] was analysed with PFAM. Multi-
domain proteins were not found in this list and immuno-
globulin or fibronectin domains, which are frequent in
extracellular multidomain regions, were not present. This
result corresponds to the thickness of the lysosomal gly-
coprotein coat of 8 nm on average, which is low in com-
parison to the glycocalyces on cell membranes of several
hundred nanometers thickness [55].
It is generally believed that intracellular glycoprotein
coats protect the limiting membranes of degradative vesi-
cles against acid hydrolases. LAMP-1 protects natural
killer cells against their own cytotoxic effectors. Besides
protection, glycoconjugate coats on membranes of lyso-
somes and granules might be important in preventing
attachment of the condensed content with the mem-
brane, thereby supporting release of the content during
phago-lysosomal fusion or exocytosis, respectively.
Conclusion
This paper shows that the conserved domain of lysosome-
associated membrane proteins forms a previously
unknown b-prism fold with several unique structural fea-
tures. The low thickness of the lysosomal inner membrane
coat correlates with the compactness and membrane-
proximity of the luminal regions of the heavily glycosy-
lated lysosomal membrane proteins. Knowledge of the
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LAMPs’ globular domains and their sites of possible mole-
cular interaction will support continued research on the
role of these proteins in the cell.
Methods
Multiple alignment, modelling
Multiple alignments were made with Jalview [56] and the
L-INS-i method of MAFFT [57]. Comparative modelling
of LAMP domains was performed with MODELLER (Uni-
versity of California, San Francisco, CA, USA) [46]. Com-
plex type N-linked glycans were attached to structural
models with the GLYPROT server [47]. The attached gly-
can was a 17-mer with 4 sialylated N-acetyllactosamine
antenna (LinucsID 26155 in the Glycosciences glycan
database [47]).
A structural representation of the linker 196PSPTTAP-
PAPPSPSPSP212 between the domains of human LAMP-1
was created in an elongated conformation (F, Ψ approxi-
mately -82°, 125°) with PyMOL (Schrödinger LLC, New
York, NY, USA) and Swiss-PdbViewer [58]. The sialylated
trisaccharide aNeu5Ac(2-3)bGal(1-3)aGalNAc was
attached to the 6 reported O-glycosylation sites [59] using
GLYCAM [48]. Molecular dynamics simulations were per-
formed with AMBER11 [60] and the GLYCAM06 force
field [61] in an implicit generalized Born solvent. The
initial structure was minimized by 500 steps of steepest
descent followed by 500 of conjugate gradient. Then, the
system was heated, with a time step of 0.5 fs, for 1 ps at
10 K, followed by a gradient of 4 ps to 300 K and an equi-
libration step of 500 ps at 300 K. The heated system was
subjected to 12 ns simulation at 300 K with a time step of
2 fs and a heat bath coupling time constant of 0.5 ps.
Protein production, crystallization, and heavy metal
derivatization
The membrane-proximal domain of human DC-LAMP
(UniProt Q9UQV4, 222-381) with a C-terminal His6-tag
was produced with a stable CHO cell line, purified by
nickel chromatography and gelfiltration, deglycosylated
and crystallized as described [38,39]. Crystals were
soaked for 0.5 to 10 minutes in 14 mM Ammonium hex-
achloriridate(III)hydrate (Hampton Research, Aliso Viejo,
CA, USA) in mother liquor and immediately shock
cooled in liquid nitrogen.
Data collection and structure determination
Three sets of X-ray diffraction data were collected at
beamline X12 of the EMBL outstation (Hamburg, Ger-
many) at wavelengths of 1.10371, 1.10420 and 1.10009
Å which correspond to the peak, inflection point and
high-energy remote of the Ir absorption spectrum,
respectively. Data were processed with XDS [62] in
space group P31 to a high-resolution limit of 2.8 Å. The
calculation of the Matthews coefficient [63] and a
MOLREP self-rotation function [64] revealed the pre-
sence of two DC-LAMP molecules in the asymmetric
unit. The phase problem was solved by multi-wave-
length anomalous dispersion with Phenix.autosol of the
Phenix software suite [65]. Phenix.autobuild was used to
build an initial model of DC-LAMP but succeeded only
in building parts of one of the two molecules in the
asymmetric unit. This partial model was used as a
search model for molecular replacement with Phaser
[66], which resulted in the positions of both DC-LAMP
molecules. The structure was completed by iterative
steps of manual rebuilding in Coot [67] and refinement
with Phenix.refine [65]. The complete data collection
and refinement statistics are shown in Table 1. Superpo-
sitions were carried out and r.m.s. deviations were cal-
culated with the UCSF Chimera package (University of
California, San Francisco, CA, USA) [68]. The secondary
structure was analyzed using the DSSP algorithm [69]
and figures were prepared with PyMOL.
PDB Accession Code
Coordinates and experimental structure factors have
been deposited in the Protein Data Bank with accession
code [PDB:4AKM].
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